echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Following Pfizer, Merck's new pneumonia vaccine was approved by the FDA

    Following Pfizer, Merck's new pneumonia vaccine was approved by the FDA

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    More than a month ago, Pfizer (Pfizer) introduced an improved version of the pneumonia vaccine.


    Both of these new vaccines provide better protection against bacteria that cause pneumonia, meningitis and blood infections, as well as a variety of ear and sinus infections


    Merck said Friday that the U.


    Merck has not disclosed the price of its injection or when it will be launched


    Pfizer’s latest vaccine, Prevnar20, was approved for use in adults on June 8


    A team of vaccine experts from the US Centers for Disease Control and Prevention will evaluate the two vaccines in October and recommend who should be vaccinated


    Pfizer’s new vaccine protects against more than 7 more pathogens than the 10-year-old Prevnar 13-valent vaccine.


    Merck said that tests have shown that its new vaccine is as effective as Prevnar13 against strains that both vaccines can fight against, but it is more effective against one of the strains


    Merck and Pfizer have been testing their vaccines on children and infants and plan to seek approval for these age groups


    At the same time, Merck will continue to sell its 38-year-old pneumococcal 23-valent vaccine, which can prevent 23 strains and is approved for use in children



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.